Premium
Atrial Fibrillation and Mitral Valve Repair
Author(s) -
JOVIN ANGELIKA,
OPREA DANA A.,
JOVIN ION S.,
HASHIM SABET W.,
CLANCY JUDE F.
Publication year - 2008
Publication title -
pacing and clinical electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 101
eISSN - 1540-8159
pISSN - 0147-8389
DOI - 10.1111/j.1540-8159.2008.01135.x
Subject(s) - medicine , atrial fibrillation , sinus rhythm , mitral valve , mitral valve repair , cardiology , concomitant , mitral valve replacement , surgery
Atrial fibrillation (AF) is present in 30–40% of patients presenting for mitral valve surgery. In patients undergoing mitral valve repair, the presence of AF may be associated with increased mortality and morbidity and this is also the case in patients in whom AF persists postoperatively. Advances in understanding the pathogenesis of AF led to techniques that include both mitral valve repair and ablation of AF. The concomitant surgical treatment of AF during mitral surgery has become a commonly performed procedure, which was shown to be safe and which may improve the outcome for patients. AF after mitral valve replacement is an accepted indication for anticoagulation, but the data supporting anticoagulation in patients after mitral valverepair who convert to sinus rhythm are sparse. This article reviews the available data regarding outcomes of mitral repair and how they are influenced by AF and its therapy.